What Do the Statin Trials Tell Us?

New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.

Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.

Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.

Simple operational changes are proving more effective at closing gaps in cardiovascular-kidney-metabolic (CKM) syndrome care than education campaigns alone, according to panelists at at Population Health Roundtable

Panelists at AJMC roundtables in Philadelphia, Boston, Washington, DC, and Chicago traced why atopic dermatitis stays undertreated despite new therapies.

Eye care access for underserved patients with diabetes is limited and poorly understood. We identified barriers and innovative solutions to improve overall care and establish evidence-based practices.

Patient understanding should be treated as a measurable equity outcome, not an assumed byproduct of care.

The Right Care Initiative provides a proven, scalable framework for reducing preventable cardiovascular deaths. By integrating interorganizational learning, pharmacist-led care, and precision screening (coronary artery calcium imaging), the model bridges the 17-year implementation gap between clinical evidence and improved population health.